These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8467843)

  • 1. Soluble class I antigen secretion by peripheral blood lymphocytes in multiple sclerosis.
    Alvarez-Cermeño JC; Brieva JA; Villar LM; Roldán E; Bootello A; González-Porqué P
    Eur Neurol; 1993; 33(3):229-31. PubMed ID: 8467843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble HLA class I and class II antigens in patients with multiple sclerosis.
    Ott M; Seidl C; Westhoff U; Stecker K; Seifried E; Fischer PA; Grosse-Wilde H
    Tissue Antigens; 1998 Mar; 51(3):301-4. PubMed ID: 9550332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.
    Fainardi E; Rizzo R; Melchiorri L; Castellazzi M; Paolino E; Tola MR; Granieri E; Baricordi OR
    Mult Scler; 2006 Feb; 12(1):2-12. PubMed ID: 16459714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-beta1a treatment and their use as markers of disease activity.
    Minagar A; Adamashvilli I; Jaffe SL; Glabus MF; Gonzalez-Toledo E; Kelley RE
    Ann N Y Acad Sci; 2005 Jun; 1051():111-20. PubMed ID: 16126950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis.
    Rizzo R; Pietrobon S; Mazzoni E; Bortolotti D; Martini F; Castellazzi M; Casetta I; Fainardi E; Di Luca D; Granieri E; Tognon M;
    J Transl Med; 2016 Jul; 14(1):216. PubMed ID: 27443345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal synthesis of soluble class I antigens in multiple sclerosis.
    Alvarez-Cermeño JC; Villar LM; Nocito M; Bootello A; González-Porqué P
    J Neuroimmunol; 1992 Jan; 36(1):77-9. PubMed ID: 1735771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal functional capacity of blood lymphocytes in multiple sclerosis measured by stimulation with mitogens.
    Kinnman J; Link H; Frydén A
    Eur Neurol; 1979; 18(3):189-93. PubMed ID: 477690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis.
    Fainardi E; Rizzo R; Castellazzi M; Stignani M; Granieri E; Baricordi OR
    Hum Immunol; 2009 Dec; 70(12):981-7. PubMed ID: 19651179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of peptide-loaded HLA class I molecules on multiple sclerosis lymphocytes.
    Li F; Linan MJ; Stein MC; Faustman DL
    Ann Neurol; 1995 Aug; 38(2):147-54. PubMed ID: 7654061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
    Hafler DA; Fox DA; Manning ME; Schlossman SF; Reinherz EL; Weiner HL
    N Engl J Med; 1985 May; 312(22):1405-11. PubMed ID: 2985995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis.
    Brucklacher-Waldert V; Stuerner K; Kolster M; Wolthausen J; Tolosa E
    Brain; 2009 Dec; 132(Pt 12):3329-41. PubMed ID: 19933767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphocyte subpopulations in multiple sclerosis (MS). A contribution].
    Nuccetelli F; Assetta M; Tartaro A; Di Muzio A; Nanni Costa E; Anichini M; Gambi D
    Minerva Med; 1989 Mar; 80(3):189-93. PubMed ID: 2654756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte activation in discordant multiple sclerosis twin pairs.
    Konttinen YT; Kinnunen E; Kemppinen P; Juntunen J; Koskenvuo M
    J Neuroimmunol; 1990 Apr; 27(1):1-8. PubMed ID: 1690751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated T lymphocytes in patients with multiple sclerosis in clinical remission.
    Konttinen YT; Bergroth V; Kinnunen E; Nordström D; Kouri T
    J Neurol Sci; 1987 Nov; 81(2-3):133-9. PubMed ID: 3121798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma and interleukin-4-producing T cells in peripheral blood of multiple sclerosis patients.
    Franciotta D; Zardini E; Bergamaschi R; Andreoni L; Cosi V
    Eur Cytokine Netw; 2000 Dec; 11(4):677-81. PubMed ID: 11125313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients.
    Schmidt S; Moric E; Schmidt M; Sastre M; Feinstein DL; Heneka MT
    J Leukoc Biol; 2004 Mar; 75(3):478-85. PubMed ID: 14657213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.